Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on August 1, 2006

Published online before print June 12, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.1005592v1
80/2/278    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dauer, M.
Right arrow Articles by Eigler, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dauer, M.
Right arrow Articles by Eigler, A.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.1005592


Received for publication October 19, 2005.
Revised February 27, 2006.
Accepted for publication April 13, 2006.


Article

IFN-{alpha} promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4

Marc Dauer , Katharina Schad , Jana Junkmann , Christian Bauer , Jan Herten , Rosemarie Kiefl , Max Schnurr , Stefan Endres , and Andreas Eigler @

Section of Gastroenterology and Division of Clinical Pharmacology, Medizinische Klinik Innenstadt, University of Munich, Germany

@ To whom correspondence should be addressed. E-mail: Eigler{at}lmu.de.


   Abstract

Dendritic cells (DC) generated in vitro have to be viable and phenotypically mature to be capable of inducing T cell-mediated immunity after in vivo administration. To facilitate optimization of DC-based vaccination protocols, we investigated whether the cytokine environment and the mode of activation affect maturation and survival of DC derived from monocytes by a short-term protocol. Monocytes cultured for 24 h with granulocyte macrophage-colony stimulating factor and interleukin-4 were stimulated with proinflammatory mediators for another 36 h to generate mature DC. Additional activation with CD40 ligand and interferon (IFN)-{gamma} increased viability of DC and promoted definitive maturation as defined by maintenance of a mature phenotype after withdrawal of cytokines. Addition of IFN-{alpha} to DC cultures prior to stimulation further enhanced definitive maturation: IFN-{alpha}-primed DC expressed high levels of costimulatory molecules and CC chemokine receptor 7 (CCR7) up to 5 days after cytokine withdrawal. Compared with unprimed DC, IFN-{alpha}-primed DC displayed equal capacity to migrate upon CCR7 ligation and to prime antigen-specific T helper cell as well as cytolytic T cell responses. In conclusion, we show that optimal maturation and survival of monocyte-derived DC require multiple activation signals. Furthermore, we identified a novel role for IFN-{alpha} in DC development: IFN-{alpha} priming of monocytes promotes definitive maturation of DC upon activation.

Key Words: differentiation • viability • priming • T cells • vaccination • immunotherapy




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
V. Veckman and I. Julkunen
Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells
J. Leukoc. Biol., February 1, 2008; 83(2): 296 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Sriram, C. Biswas, E. M. Behrens, J.-A. Dinnall, D. K. Shivers, M. Monestier, Y. Argon, and S. Gallucci
IL-4 Suppresses Dendritic Cell Response to Type I Interferons
J. Immunol., November 15, 2007; 179(10): 6446 - 6455.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Romieu-Mourez, M. Solis, A. Nardin, D. Goubau, V. Baron-Bodo, R. Lin, B. Massie, M. Salcedo, and J. Hiscott
Distinct Roles for IFN Regulatory Factor (IRF)-3 and IRF-7 in the Activation of Antitumor Properties of Human Macrophages
Cancer Res., November 1, 2006; 66(21): 10576 - 10585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.